Skip to main content
. 2021 Feb 17;14:1756286420987031. doi: 10.1177/1756286420987031

Figure 1.

Figure 1.

Trends in annual price for DMTs for MS by class; 1997–2020. Unadjusted annual price estimated from wholesale acquisition costs (First Databank). The annual price for Lemtrada is based on four 12 mg vials [Package insert dosing: 12 mg/day (5 vials) for five consecutive days in first year; 12 mg/day (3 vials) for 3 days in year 2]. Market introduction date in parenthesis. Updated 12 August 2020 (data through July 2020).

DMT, disease-modifying therapies; MS, multiple sclerosis.